Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A0A3Q8ILP4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 164 | 168 | PF00656 | 0.570 |
CLV_C14_Caspase3-7 | 79 | 83 | PF00656 | 0.502 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.646 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.578 |
CLV_PCSK_FUR_1 | 110 | 114 | PF00082 | 0.441 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.579 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.578 |
CLV_PCSK_PC1ET2_1 | 112 | 114 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.626 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.525 |
CLV_PCSK_SKI1_1 | 196 | 200 | PF00082 | 0.697 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.592 |
CLV_Separin_Metazoa | 106 | 110 | PF03568 | 0.666 |
CLV_Separin_Metazoa | 68 | 72 | PF03568 | 0.661 |
DEG_APCC_DBOX_1 | 169 | 177 | PF00400 | 0.602 |
DEG_APCC_DBOX_1 | 66 | 74 | PF00400 | 0.661 |
DOC_MAPK_gen_1 | 32 | 41 | PF00069 | 0.651 |
DOC_MAPK_MEF2A_6 | 71 | 78 | PF00069 | 0.599 |
DOC_MAPK_NFAT4_5 | 71 | 79 | PF00069 | 0.600 |
DOC_PP2B_LxvP_1 | 144 | 147 | PF13499 | 0.683 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.712 |
DOC_WW_Pin1_4 | 165 | 170 | PF00397 | 0.562 |
LIG_14-3-3_CanoR_1 | 50 | 58 | PF00244 | 0.471 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.726 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.676 |
LIG_FHA_1 | 32 | 38 | PF00498 | 0.631 |
LIG_FHA_1 | 98 | 104 | PF00498 | 0.632 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.717 |
LIG_FHA_2 | 63 | 69 | PF00498 | 0.631 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.494 |
LIG_NRBOX | 69 | 75 | PF00104 | 0.670 |
LIG_PDZ_Class_2 | 195 | 200 | PF00595 | 0.590 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.681 |
LIG_TRAF2_1 | 40 | 43 | PF00917 | 0.564 |
MOD_CDK_SPK_2 | 165 | 170 | PF00069 | 0.520 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.612 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.776 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.688 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.548 |
MOD_CK2_1 | 156 | 162 | PF00069 | 0.740 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.541 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.634 |
MOD_GlcNHglycan | 10 | 14 | PF01048 | 0.754 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.558 |
MOD_GlcNHglycan | 154 | 157 | PF01048 | 0.743 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.425 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.660 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.763 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.622 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.641 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.775 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.597 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.601 |
MOD_PIKK_1 | 116 | 122 | PF00454 | 0.575 |
MOD_PK_1 | 125 | 131 | PF00069 | 0.587 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.556 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.571 |
MOD_Plk_1 | 187 | 193 | PF00069 | 0.535 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.669 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.496 |
MOD_ProDKin_1 | 165 | 171 | PF00069 | 0.558 |
MOD_SUMO_for_1 | 179 | 182 | PF00179 | 0.638 |
MOD_SUMO_rev_2 | 174 | 181 | PF00179 | 0.598 |
TRG_ER_diArg_1 | 108 | 110 | PF00400 | 0.550 |
TRG_ER_diArg_1 | 58 | 60 | PF00400 | 0.569 |
TRG_NES_CRM1_1 | 68 | 82 | PF08389 | 0.680 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVP8 | Leptomonas seymouri | 34% | 97% |
A4HKZ9 | Leishmania braziliensis | 62% | 100% |
A4I8I0 | Leishmania infantum | 100% | 100% |
E9B3E0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q4R2 | Leishmania major | 90% | 100% |